Catherine Sabatos-Peyton is a cancer immunologist turned biotech CEO who runs Larkspur Biosciences, a Cambridge, Massachusetts company building small-molecule drugs that attack cancer's ability to hide from the immune system. As a Harvard PhD student she helped first describe TIM-3, now a major checkpoint protein; she later led discovery of the anti-TIM-3 antibody sabatolimab at CoStim and Novartis. In 2021 she stepped from the lab bench to the corner office, and now leads an all-female executive team whose lead drug, the PIP4K2C degrader LRK-4189, entered human trials in late 2025.
Felix González Herranz is the Co-Founder and CEO of FounderNest, an AI-powered market intelligence platform serving Fortune 500 companies with tools for innovation scouting, competitive analysis, and M&A research. A Fulbright Scholar and Stanford GSB Arjay Miller Scholar, Felix built FounderNest from a problem he lived firsthand - helping companies find signal in a sea of 54 million company profiles. Before FounderNest, he worked at the Inter-American Development Bank across 20+ countries, consulted at The World Bank, and co-founded JuntoSalimos during Spain's 2009 economic crisis to support Spanish-speaking entrepreneurs. His clients include L'Oréal, Roche, Telefónica, AstraZeneca, and Novo Nordisk.
Josh Tetrick is the co-founder and CEO of Eat Just, Inc., the San Francisco-based food technology company behind JUST Egg (a mung bean-based egg substitute) and GOOD Meat (the world's first commercially sold cultivated chicken). Starting with $37,000 of personal capital in 2011, he has raised over $456 million to build a company that simultaneously cracked the plant-based egg market and won the world's first regulatory approval for lab-grown meat in Singapore in 2020. A former Fulbright Scholar, UN initiative leader, and Cornell-educated lawyer turned food disruptor, Tetrick has made it his life's work to prove that removing animals from the food system doesn't mean sacrificing flavor or scale.
Adam Joseph is the Founder and CEO of Clipbook, the AI system of record for communications and public affairs teams. A Harvard summa cum laude graduate and Fulbright Scholar, he bootstrapped Clipbook to $1M ARR before landing a $3.3M seed round co-led by Mark Cuban - won through a single cold email. Before building Clipbook, he served as Communications Director for Abdul El-Sayed's historic 2018 Michigan gubernatorial campaign and as a Strategy Consultant at BCG, where he led healthcare and government transformation work. Clipbook now monitors 1M+ media and policy sources for 200+ clients including Weber Shandwick and BCG.
Niko Bonatsos is a Greek-born, Stanford-educated venture capitalist who spent 15 years at General Catalyst building one of Silicon Valley's strongest seed-stage consumer investment track records - backing Snap, Discord, Mercor, ClassDojo, and Dubsmash before most people knew they existed. In January 2026 he left General Catalyst to co-found Verdict Capital with Michael Fertik, targeting a $300M fund focused on seed/Series A investing in consumer and AI, with a particular contrarian bet on consumer AI being underappreciated in an enterprise-saturated market.
Omri Amirav-Drory, Ph.D., is a General Partner at NFX leading NFX Bio, a pre-seed and seed venture fund focused on scientist-founders at the intersection of technology and biology. A former Fulbright Scholar and Stanford postdoc turned biotech entrepreneur, he co-founded Genome Compiler (acquired by Twist Bioscience), launched Tech.Bio, and now backs breakthrough life sciences companies while co-founding Renewal Bio - a longevity company building synthetic embryo-derived tissues to combat aging. His stated mission is ending involuntary death.